A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study

Harry Buller; Anthonie Lensing; M Prins; G Agnelli; A Cohen; Alexander Gallus; F Misselwitz; G Raskob; Sebastian Schellong; Annelise Segers

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study

Harry Buller, Anthonie Lensing, M Prins, G Agnelli, A Cohen, Alexander Gallus, F Misselwitz, G Raskob, Sebastian Schellong, Annelise Segers

Research output: Contribution to journal › Article › peer-review

338 Citations (Scopus)

Original language	English
Pages (from-to)	2242-2247
Number of pages	6
Journal	Blood
Volume	112
Issue number	6
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Buller, H., Lensing, A., Prins, M., Agnelli, G., Cohen, A., Gallus, A., Misselwitz, F., Raskob, G., Schellong, S., & Segers, A. (2008). A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study. Blood, 112(6), 2242-2247.

@article{cb9cd9c1aeba40b39b9b46c4a22a280e,

title = "A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study",

author = "Harry Buller and Anthonie Lensing and M Prins and G Agnelli and A Cohen and Alexander Gallus and F Misselwitz and G Raskob and Sebastian Schellong and Annelise Segers",

year = "2008",

language = "English",

volume = "112",

pages = "2242--2247",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "6",

}

Buller, H, Lensing, A, Prins, M, Agnelli, G, Cohen, A, Gallus, A, Misselwitz, F, Raskob, G, Schellong, S & Segers, A 2008, 'A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study', Blood, vol. 112, no. 6, pp. 2242-2247.

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study. / Buller, Harry; Lensing, Anthonie; Prins, M et al.
In: Blood, Vol. 112, No. 6, 2008, p. 2242-2247.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study

AU - Buller, Harry

AU - Lensing, Anthonie

AU - Prins, M

AU - Agnelli, G

AU - Cohen, A

AU - Gallus, Alexander

AU - Misselwitz, F

AU - Raskob, G

AU - Schellong, Sebastian

AU - Segers, Annelise

PY - 2008

Y1 - 2008

M3 - Article

SN - 0006-4971

VL - 112

SP - 2242

EP - 2247

JO - Blood

JF - Blood

IS - 6

ER -